Pharmaceutical Industry
HealthHorseshoe crab blood is vital to modern medicine. A new lab-made alternative could save the species
By Kristoffer Whitney, Jolie Crunelle and The ConversationOctober 13, 2023
HealthCVS CEO says pharmacist burnout led to a walkout: ‘We are at the same level of demand as we were in 2021’ for COVID shots
By Erin PraterOctober 10, 2023
FinanceWall Street is now betting against restaurant stocks because of Novo Nordisk’s Ozempic and high interest rates
By Prarthana PrakashOctober 10, 2023
Health‘These pharmacists always look stressed’: Drugstores struggle with thin staffing and recruiting challenges as busiest season begins
By Tom Murphy and The Associated PressOctober 7, 2023
LifestyleWeight-loss-aiding drugs Ozempic and Wegovy are dampening food sales, top Walmart exec says
By Chloe TaylorOctober 5, 2023
FinanceDrugs aiding weight-loss like Ozempic have so much promise, a major bank is telling investors to short junk-food credit
By Prarthana PrakashOctober 4, 2023
HealthOzempic and Wegovy ‘significantly’ improve blood sugar and weight for the long-term, new study suggests
By Erin PraterOctober 2, 2023
SuccessCVS is promising to boost hiring after overworked pharmacists don’t show up, but longterm solution to worker shortage is elusive
By Josh Funk and The Associated PressSeptember 28, 2023
By Howard DeanSeptember 19, 2023
RetailWegovy maker Novo Nordisk leapfrogs LVMH to become Europe’s most valuable company after it takes its ‘miracle’ weight loss drug to the U.K.
By Prarthana PrakashSeptember 5, 2023
CommentarySmoke and mirrors: I’ve been debating Vivek Ramaswamy for 2 years. Here’s how I got past his diversionary tactics
By Jeffrey SonnenfeldAugust 31, 2023
CommentaryU.S. health care has been in crisis since Nixon–but two economists may have found a way to radically disrupt it
By John G. SingerAugust 10, 2023
HealthPopular weight-loss injectable Wegovy cuts risk of heart attack and stroke by 20%, company says
By Erin PraterAugust 8, 2023
Most Popular
